| Not Yet Recruiting | Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study Dyslipidemia | — | 2026-04-30 |
| Not Yet Recruiting | Noseguard for Prevention of Respiratory Infections in Real-World Use Respiratory Infection Virus, COVID-19, Influenza | N/A | 2026-04-20 |
| Not Yet Recruiting | Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer NSAID (Non-Steroidal Anti-Inflammatory Drug) | Phase 4 | 2026-04-01 |
| Recruiting | Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer Cancer, Ovarian Cancer | Phase 1 | 2026-02-20 |
| Recruiting | Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy V Healthy Volunteers | Phase 1 | 2025-12-01 |
| Completed | PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers Healthy Subjects | Phase 1 | 2025-11-14 |
| Completed | Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults Healthy | Phase 1 | 2025-11-09 |
| Recruiting | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy V Healthy Volunteers | Phase 1 | 2025-11-05 |
| Not Yet Recruiting | Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis Psoriasis | — | 2025-09-30 |
| Recruiting | Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients Wi Stage 1 Hypertension | — | 2025-09-17 |
| Recruiting | PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers Healthy Subjects | Phase 1 | 2025-09-01 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines Glabellar Lines | Phase 3 | 2025-07-15 |
| Recruiting | Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis Gastritis | — | 2025-06-17 |
| Completed | A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension Essential Hypertension | Phase 3 | 2025-02-24 |
| Completed | Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension Hypertension, Essential Hypertension | Phase 3 | 2025-01-01 |
| Recruiting | A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunte Autoimmune Diseases | Phase 1 | 2024-12-10 |
| Recruiting | Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia Diabetes Mellitus, Type 2 | — | 2024-12-03 |
| Not Yet Recruiting | Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults Healthy | Phase 1 | 2024-10-26 |
| Not Yet Recruiting | Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315 Healthy Volunteers | Phase 1 | 2024-10-01 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Pat Type 2 Diabetic Nephropathy | Phase 3 | 2024-09-23 |
| Not Yet Recruiting | to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection Erosive Gastroesophageal Reflux Disease | Phase 1 | 2024-07-01 |
| Active Not Recruiting | Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type Type 2 Diabetes | — | 2024-06-11 |
| Active Not Recruiting | Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With T Type 2 Diabetes Mellitus | — | 2024-06-11 |
| Completed | Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy; Colonoscopy | Phase 3 | 2024-03-08 |
| Completed | Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylo Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects | Phase 3 | 2024-02-06 |
| Unknown | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus T2DM (Type 2 Diabetes Mellitus) | Phase 3 | 2023-12-01 |
| Completed | Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines Glabellar Lines | Phase 1 | 2023-11-28 |
| Unknown | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers Healthy Volunteers | Phase 1 | 2023-11-09 |
| Unknown | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers Healthy Volunteers | Phase 1 | 2023-11-06 |
| Unknown | Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects Drug Drug Interaction | Phase 1 | 2023-10-27 |
| Active Not Recruiting | To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Me Diabetes Mellitus, Type 2 | — | 2023-09-21 |
| Unknown | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Dis Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Esophageal Reflux Disease | Phase 3 | 2023-08-31 |
| Completed | Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated Hepatitis B, Chronic | Phase 4 | 2023-08-28 |
| Unknown | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers Healthy Volunteers | Phase 1 | 2023-08-17 |
| Unknown | Evaluate the Efficacy and Safety of DWJ108J Central Precocious Puberty | Phase 3 | 2023-08-01 |
| Unknown | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunt Healthy Volunteers | Phase 1 | 2023-08-01 |
| Unknown | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers Healthy Volunteers | Phase 1 | 2023-08-01 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of CREZET Tablet Dyslipidemias | — | 2023-05-24 |
| Completed | Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet Gastroesophageal Reflux Disease | — | 2023-05-22 |
| Recruiting | To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Diabetes Mellitus, Type 2 | Phase 1 | 2023-04-13 |
| Recruiting | A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mel Type 2 Diabetes Mellitus | Phase 3 | 2023-03-17 |
| Unknown | To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers Healthy | Phase 1 | 2023-03-09 |
| Unknown | A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Mal Phase 1 Study, Healthy Volunteers | Phase 1 | 2023-02-27 |
| Unknown | Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects Drug-drug Interaction | Phase 1 | 2023-02-15 |
| Completed | Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease Chronic Liver Disease | Phase 4 | 2023-02-06 |
| Unknown | To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination FDC, Diabetes Mellitus, Type 2 | Phase 1 | 2023-01-25 |
| Unknown | A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patien Hypertension, Hyperlipidemias | Phase 3 | 2022-12-01 |
| Completed | A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab Gastroesophageal Reflux Disease | — | 2022-11-11 |
| Unknown | Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subj Drug Drug Interaction | Phase 1 | 2022-10-26 |
| Withdrawn | The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects Healthy | Phase 1 | 2022-10-01 |
| Active Not Recruiting | The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Diabetes Mellitus, Diabetes Mellitus, Type 2, Glucose Metabolism Disorders | Phase 3 | 2022-09-28 |
| Completed | Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects Drug Drug Interaction | Phase 1 | 2022-09-21 |
| Unknown | Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults Healthy | Phase 1 | 2022-08-26 |
| Completed | Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Diarrhea | Phase 1 | 2022-08-22 |
| Recruiting | Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF Idiopathic Pulmonary Fibrosis | Phase 2 | 2022-07-29 |
| Completed | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C Healthy Volunteers | Phase 1 | 2022-07-22 |
| Active Not Recruiting | Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment Dyslipidemias | — | 2022-07-08 |
| Completed | Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab Gastroesophageal Reflux Disease | — | 2022-07-06 |
| Active Not Recruiting | Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patien Hypertension, Dyslipidemias | — | 2022-06-20 |
| Active Not Recruiting | Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Co Hyperlipidemias, Hypertension | — | 2022-06-20 |
| Completed | DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities Rash Acneiform | Phase 2 | 2022-05-02 |
| Completed | A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers Healthy | Phase 1 | 2022-04-15 |
| Terminated | Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe CO COVID-19 | Phase 2 | 2022-03-31 |
| Completed | Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects Drug Drug Interaction | Phase 1 | 2022-03-21 |
| Completed | To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis Gastritis | — | 2022-03-17 |
| Completed | Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose Osteoporosis | — | 2022-02-28 |
| Completed | To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients Dyslipidemia | — | 2022-02-28 |
| Unknown | Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities Healthy | Phase 1 | 2022-02-14 |
| Completed | An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Adminis Healthy Subject | Phase 1 | 2022-01-27 |
| Completed | Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volun Healthy Volunteers | Phase 1 | 2022-01-10 |
| Completed | The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis Reflux Esophagitis | Phase 3 | 2021-12-30 |
| Unknown | The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults Healthy Volunteers | Phase 1 | 2021-12-10 |
| Completed | Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Health Phase 1 Study, Healthy Volunteers | Phase 1 | 2021-10-01 |
| Completed | Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients Wi Gastritis | Phase 4 | 2021-09-30 |
| Completed | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM. T2DM (Type 2 Diabetes Mellitus) | Phase 3 | 2021-09-16 |
| Completed | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterecto Gastric Cancer | Phase 4 | 2021-09-15 |
| Completed | To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-07-23 |
| Completed | To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-06-30 |
| Completed | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) Type 2 Diabetes Mellitus | N/A | 2021-06-17 |
| Terminated | A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2 Covid19, SARS-COV-2 Infection | Phase 3 | 2021-06-07 |
| Completed | Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately T2DM (Type 2 Diabetes Mellitus) | Phase 3 | 2021-05-25 |
| Completed | Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer Peptic Ulcer | Phase 3 | 2021-05-21 |
| Completed | Pharmacokinetics and Safety Following Administration of DWP16001 Healthy | Phase 1 | 2021-05-01 |
| Completed | To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-03-22 |
| Unknown | Pharmacokinetics and Safety of DWJ1451 in Healthy Adults Healthy | Phase 1 | 2021-03-13 |
| Completed | Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers Healthy | Phase 1 | 2021-03-12 |
| Terminated | Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients Severe COVID-19 | Phase 3 | 2021-02-02 |
| Unknown | Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 Dyslipidemias | Phase 3 | 2021-02-01 |
| Unknown | Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Ad Healthy | Phase 1 | 2021-01-20 |
| Completed | The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus T2DM (Type 2 Diabetes Mellitus) | Phase 3 | 2020-12-30 |
| Terminated | To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines) COVID-19 Patients | Phase 1 | 2020-12-04 |
| Completed | To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which i Covid19 | Phase 1 | 2020-11-21 |
| Completed | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. T2DM (Type 2 Diabetes Mellitus) | Phase 3 | 2020-11-18 |
| Unknown | Treatment Effect According to Timing of Administration of DWP14012 40 mg Erosive Esophagitis | N/A | 2020-11-17 |
| Completed | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. T2DM (Type 2 Diabetes Mellitus) | Phase 3 | 2020-11-11 |
| Unknown | To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 COVID-19 Patients | Phase 1 | 2020-10-19 |
| Terminated | Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo Mild to Moderate COVID-19 | Phase 2 / Phase 3 | 2020-09-11 |
| Completed | Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers Drug-drug Interaction | Phase 1 | 2020-09-06 |
| Completed | DWP450 for Treating Moderate to Severe Glabellar Lines Moderate to Severe Glabellar Lines | Phase 3 | 2020-08-12 |
| Unknown | Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers Healthy | Phase 1 | 2020-08-06 |
| Unknown | To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19 Healthy | Phase 1 | 2020-08-01 |
| Unknown | Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive E Healed Erosive Esophagitis | Phase 3 | 2020-07-02 |
| Unknown | Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs Healthy Male Volunteers | Phase 1 | 2020-06-19 |
| Completed | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis Acute Gastritis, Chronic Gastritis | Phase 3 | 2020-06-02 |
| Withdrawn | Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults Healthy | Phase 1 | 2020-05-28 |
| Unknown | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Mal Healthy | Phase 1 | 2020-04-01 |
| Completed | Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy Benign Masseteric Hypertrophy | Phase 3 | 2020-03-04 |
| Completed | Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate Chronic Occlusive Arterial Disease | — | 2020-01-28 |
| Unknown | Type 2 Diabetes Patients With Renal Impairment Type2 Diabetes | Phase 1 | 2020-01-01 |
| Completed | Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers Healthy | Phase 1 | 2019-12-24 |
| Unknown | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III) Healthy | Phase 1 | 2019-12-14 |
| Completed | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab Hypertension, Dyslipidemia | — | 2019-12-01 |
| Unknown | Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 Hypertension, Dyslipidemia | Phase 3 | 2019-11-20 |
| Unknown | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II) Healthy | Phase 1 | 2019-11-01 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab Hypertension, Dyslipidemias | Phase 4 | 2019-08-26 |
| Completed | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phas Healthy | Phase 1 | 2019-08-14 |
| Unknown | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus T2DM (Type 2 Diabetes Mellitus) | Phase 2 | 2019-07-10 |
| Completed | Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers Healthy | Phase 1 | 2019-07-02 |
| Unknown | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers Healthy | Phase 1 | 2019-06-01 |
| Completed | Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat Submental Fat | Phase 3 | 2019-05-15 |
| Unknown | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions Healthy | Phase 1 | 2019-03-04 |
| Completed | Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions Healthy | Phase 1 | 2019-03-04 |
| Unknown | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease Non-Erosive Gastroesophageal Reflux Disease | Phase 3 | 2019-02-07 |
| Completed | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease Erosive Esophagitis | Phase 3 | 2018-12-13 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy J Healthy Volunteers | Phase 1 | 2018-11-01 |
| Completed | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under F Healthy | Phase 1 | 2018-05-31 |
| Completed | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under F Healthy | Phase 1 | 2018-05-31 |
| Completed | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Com Healthy | Phase 1 | 2018-04-08 |
| Completed | Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients Hepatitis B, Chronic | Phase 4 | 2018-01-23 |
| Completed | Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 Healthy | Phase 1 | 2017-12-22 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy M Healthy | Phase 1 | 2017-12-03 |
| Unknown | DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy Benign Masseteric Hypertrophy | Phase 2 | 2017-12-01 |
| Completed | Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat Treatment for Submental Fat | Phase 2 | 2017-10-26 |
| Completed | A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Condi Healthy | Phase 1 | 2017-10-01 |
| Completed | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease Erosive Gastroesophageal Reflux Disease | Phase 2 | 2017-08-28 |
| Terminated | Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis Gastritis | Phase 3 | 2017-07-03 |
| Unknown | Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Crow's Feet Lines, Glabellar Lines | Phase 3 | 2017-07-01 |
| Completed | A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting C Healthy | Phase 1 | 2017-06-01 |
| Completed | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) Functional Dyspepsia | Phase 3 | 2017-04-24 |
| Unknown | Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients W Prostate Cancer | Phase 1 | 2017-02-01 |
| Unknown | Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers Healthy | Phase 1 | 2017-01-09 |
| Unknown | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers Healthy | Phase 1 | 2017-01-04 |
| Completed | A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatme Hypertension, Hyperlipidemias | Phase 3 | 2017-01-01 |
| Completed | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia Functional Dyspepsia | Phase 3 | 2016-12-12 |
| Completed | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers Healthy | Phase 1 | 2016-11-28 |
| Completed | Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects Healthy | Phase 1 | 2016-10-30 |
| Completed | Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm Blepharospasm | Phase 2 / Phase 3 | 2016-10-01 |
| Completed | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers Healthy | Phase 1 | 2016-09-29 |
| Unknown | Clinical Trail to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patien Patients With Thyroidecomy (Scheduled) | Phase 3 | 2016-08-01 |
| Unknown | Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hype Hypertension, Dyslipidemias | — | 2016-08-01 |
| Unknown | Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines Crows Feet Lines | Phase 2 / Phase 3 | 2016-08-01 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy M Healthy | Phase 1 | 2016-03-01 |
| Unknown | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC2 Healthy | Phase 1 | 2016-02-01 |
| Unknown | Study of DWJ1351 in Healthy Male Volunteers Healthy | Phase 1 | 2016-01-01 |
| Completed | Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects Healthy | Phase 1 | 2015-12-01 |
| Unknown | Prescription and Persistence of Antithrombotic Agents in Acute Ischemic Stroke or Transient Ischemic Attack Pa MCA - Middle Cerebral Artery Dissection | — | 2015-12-01 |
| Unknown | A Single-dose, Randomized, Two-period, Two-treatment, Two-sequence, Crossover Bioequivalence Study on a Olosta Healthy | Phase 1 | 2015-10-01 |
| Completed | Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) Type II Diabetes, Dyslipidemia | Phase 3 | 2015-08-01 |
| Unknown | A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients Alzheimer Disease | Phase 4 | 2015-07-01 |
| Completed | A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 Healthy | Phase 1 | 2015-06-01 |
| Completed | Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer Gastric Cancer | Phase 3 | 2015-05-01 |
| Completed | A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects Healthy | Phase 1 | 2015-05-01 |
| Completed | Comparative Bioavailability Study of UDCA Healthy | Phase 1 | 2015-02-01 |
| Completed | Pharmacokinetics and Drug Interaction Study Between DWC20141 and DWC20142 in Healthy Male Volunteers Healthy | Phase 1 | 2015-01-01 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liv Fatigue | Phase 4 | 2014-10-01 |
| Completed | A Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of 'Urs Fatigue | Phase 4 | 2014-10-01 |
| Completed | Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult Vo Healthy | Phase 1 | 2014-05-01 |
| Completed | Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers Healthy | Phase 1 | 2014-04-01 |
| Unknown | Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients CT Scanning Patients | — | 2014-03-01 |
| Completed | Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines Moderate-severe Glabellar Lines | Phase 4 | 2014-02-01 |
| Withdrawn | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety Metabolic Syndrome | — | 2013-10-01 |
| Completed | A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safe Spasticity, Stroke | Phase 3 | 2013-09-01 |
| Completed | Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteer Healthy | Phase 1 | 2013-09-01 |
| Completed | Clinical Study for Patients With Hypertension Associated With Dyslipidemia Hypertension, Dyslipidemia | Phase 3 | 2012-09-01 |
| Unknown | Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. A Rheumatoid Arthritis | Phase 1 | 2012-09-01 |
| Completed | Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With COPD | Phase 3 | 2012-08-01 |
| Completed | Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line Moderate to Severe Glabellar Line | Phase 3 | 2012-03-01 |
| Completed | Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia Postherpetic Neuralgia | Phase 2 | 2012-03-01 |
| Completed | Nurigra Chewable Tablet in Healthy Adult Male Volunteers Healthy | Phase 1 | 2012-02-01 |
| Completed | Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers Healthy | Phase 1 | 2012-01-01 |
| Completed | A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and Healthy Volunteers | Phase 1 | 2012-01-01 |
| Terminated | Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of DWP09031 Healthy | Phase 1 | 2012-01-01 |
| Unknown | Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndro Irritable Bowel Syndrome | Phase 4 | 2011-12-01 |
| Completed | A Single Dose Study of DWP10292 in Healthy Male Subjects Healthy | Phase 1 | 2011-08-01 |
| Completed | Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers Healthy | Phase 1 | 2011-08-01 |
| Completed | The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) Central Precocious Puberty | Phase 4 | 2011-07-01 |
| Unknown | The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients Patients Taking Low-dose Aspirin | Phase 4 | 2011-07-01 |
| Completed | Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus Diabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus | Phase 3 | 2010-10-01 |
| Completed | Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillar Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation | Phase 3 | 2010-06-01 |
| Completed | Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine Bioequivalence | Phase 1 | 2010-04-01 |
| Completed | A Multiple Dose Study of DWP05195 in Healthy Adult Subjects Healthy Adult Volunteers | Phase 1 | 2010-04-01 |
| Unknown | The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patient Stomatitis | Phase 3 | 2010-03-01 |
| Completed | DWP05195 in Healthy Adult Male Volunteers Healthy | Phase 1 | 2009-04-01 |
| Completed | Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency Growth Hormone Deficiency | Phase 3 | 2003-10-01 |